Welcome to BioSynthema

BioSynthema discovers and develops unique pharmaceuticals that are targeted to cell surface receptors overexpressed in cancer cells.  The technology makes specific tumors highly visible using diagnostic imaging methods, and enables earlier and more accurate diagnosis.  The technology is also applied to the treatment of cancer. BioSynthema is currently developing compounds that will bring new and effective products to the market for the diagnosis and treatment of neuroendocrine tumors.

New and Events

• October 15, 2007 BioSynthema and Covidien Ltd. sign exclusive agreements for cancer therapy technology.
• May 7, 2007 BioSynthema Inc., announces license agreement with Erasmus MC.

News and Events